DrugPatentWatch
DrugPatentWatch: Deep pharmaceutical intelligence with high entry pricing and a narrow market focus. Ranked #55 of 58 in Market Research Software by our editors (3.6/10); pricing: Paid; best for pharmaceutical competitive intelligence.
At a glance
- Editor score3.6 / 10
- PricingPaid
- Best forPharmaceutical competitive intelligence
- Free planNo
- Paid from$8,000/yr
- Panel accessNo
- Founded2002 · Washington, DC, United States
- Facts checked22 Sep 2026
Where it wins
- Tracks patents, FDA exclusivity, litigation, pricing, and competition
- Researches global patents across 134 countries
- Adds dashboards, alerts, AI answers, exports, and API delivery
Where it doesn't
- Starts at $1,000 per month with no free plan
- Starter limits searches and excludes exports and email alerts
- Focused on pharmaceutical intelligence rather than broad market research
Our verdict on DrugPatentWatch
DrugPatentWatch is a pharmaceutical intelligence platform for pharmaceutical and biotech companies, generic manufacturers, investors, attorneys, consultants, researchers, and healthcare organizations. It brings together drug patents, expiration dates, FDA exclusivity, regulatory data, clinical trials, pricing, sales, litigation, and competitive information. Its research scope covers generic and biosimilar entry, patent expirations, market opportunities, litigation risk, drug pipelines, and pharmaceutical business intelligence. The platform is available through the web and API, with automated reports, dashboards, alerts, exports, and an AI research assistant that provides cited answers.
Pricing creates a clear split between basic access and deeper research. The Starter plan costs $1,000 per month or $8,000 per year and includes basic searches with limited monthly searches, but no data export or email alerts. Professional costs $3,000 per month or $24,000 per year and adds single-user unlimited access, advanced and unlimited searches, data export, custom email alerts, and the Deep Research Engine. Enterprise provides bespoke solutions for teams, unlimited enterprise users, no usage logging, a dedicated account director, and an executive training program. Organizations should compare the individual-user Professional tier with Enterprise based on team requirements and governance needs.
The product’s strongest fit is specialized competitive intelligence where patent, regulatory, litigation, pricing, and global research data need to be considered together. Coverage across 134 countries, API delivery, dashboards, and alerts support recurring monitoring, while the AI research assistant can help navigate cited answers within the platform’s research workflow. Its focus is intentionally narrow: companies seeking general-purpose market research, panel access, conjoint analysis, or a broader research toolkit should look elsewhere. DrugPatentWatch is most suitable for pharmaceutical and biotech teams that can justify a substantial subscription for domain-specific intelligence; smaller teams with occasional research needs may find the Starter limits restrictive.
Your product? Our editors can test DrugPatentWatch in depth and publish a review, labelled as paid · from $149/mo →
DrugPatentWatch pricing
All 3 DrugPatentWatch plans and prices →
DrugPatentWatch fact sheet
| Free plan | No |
|---|---|
| Paid from | $8,000/yr |
| Panel access | No |
| Conjoint analysis | No |
| Advanced segmentation | Not verified |
| Reporting level | Advanced |
| Response limit | Not verified |
| User seat limit | Not verified |
| Deployment | Cloud |
| Platforms | Web |
| Support | Email, Phone |
| Built for | Small business, Mid-market, Enterprise (editorial estimate) |
| Pricing | Paid (source) |
| Website | drugpatentwatch.com |
| Facts checked | 22 Sep 2026 |
Alternatives to DrugPatentWatch
- SurveyMonkeyA flexible survey platform with branching, analysis and broad integrations.9.3
- QualtricsA broad research platform combining surveys, panels, analytics, dashboards, AI, and APIs.9.2
- AlchemerA flexible survey platform with branching, reporting, respondent panels, and API workflows.9.0
See all DrugPatentWatch alternatives →
Used DrugPatentWatch? Be the first to review it
The editor score above is our own research. What this page doesn't have yet is a reader's view — what you used DrugPatentWatch for, what worked and what didn't. No stars are seeded and no review is paid for; an editor reads every one before it appears.
Write a reviewTwo minutes · verified accounts only · read by an editor before it appears
Featured on iTechGuides
DrugPatentWatch is listed in our Market Research Software directory. Add the badge to your site — it links back to this page.
<a href="https://www.itechguides.com/products/drugpatentwatch/"><img src="https://www.itechguides.com/best/badge/drugpatentwatch.svg" alt="Featured on iTechGuides" width="230" height="46"></a>
Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Last updated · How we research and update